
|Articles|April 1, 2011
- Pharmaceutical Executive-04-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - April 2011
A Silver Lining
Advertisement
Articles in this issue
over 15 years ago
iLogisticaover 15 years ago
Off-Label But On Point?over 15 years ago
Pharm Exec Wins a Neal Award!over 15 years ago
Espacio Riescoover 15 years ago
Restoring Public Trust in Pharmaover 15 years ago
HBA Woman of the Year: Freda Lewis-Hallover 15 years ago
Revisiting ReformAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5




